Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
5
pubmed:dateCreated
2006-5-22
pubmed:abstractText
The clinical significance of portal hypertensive gastropathy (PHG) in patients with compensated liver disease is not well established. The aim of this study was to determine the prevalence and correlates of PHG in a large cohort of patients with chronic hepatitis C virus (HCV) infection and bridging fibrosis/compensated cirrhosis entering the randomized phase of the Hepatitis C Antiviral Long-term Treatment against Cirrhosis trial (HALT-C).
pubmed:grant
http://linkedlifedata.com/resource/pubmed/grant/M01RR-00042, http://linkedlifedata.com/resource/pubmed/grant/M01RR-00043, http://linkedlifedata.com/resource/pubmed/grant/M01RR-00051, http://linkedlifedata.com/resource/pubmed/grant/M01RR-00065, http://linkedlifedata.com/resource/pubmed/grant/M01RR-00633, http://linkedlifedata.com/resource/pubmed/grant/M01RR-00827, http://linkedlifedata.com/resource/pubmed/grant/M01RR-01066, http://linkedlifedata.com/resource/pubmed/grant/M01RR-06192, http://linkedlifedata.com/resource/pubmed/grant/N01-DK-9-2318, http://linkedlifedata.com/resource/pubmed/grant/N01-DK-9-2319, http://linkedlifedata.com/resource/pubmed/grant/N01-DK-9-2320, http://linkedlifedata.com/resource/pubmed/grant/N01-DK-9-2321, http://linkedlifedata.com/resource/pubmed/grant/N01-DK-9-2322, http://linkedlifedata.com/resource/pubmed/grant/N01-DK-9-2323, http://linkedlifedata.com/resource/pubmed/grant/N01-DK-9-2324, http://linkedlifedata.com/resource/pubmed/grant/N01-DK-9-2325, http://linkedlifedata.com/resource/pubmed/grant/N01-DK-9-2326, http://linkedlifedata.com/resource/pubmed/grant/N01-DK-9-2327, http://linkedlifedata.com/resource/pubmed/grant/N01-DK-9-2328
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
May
pubmed:issn
0002-9270
pubmed:author
pubmed:issnType
Print
pubmed:volume
101
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
983-92
pubmed:dateRevised
2007-11-14
pubmed:meshHeading
pubmed-meshheading:16573786-Anti-Inflammatory Agents, Non-Steroidal, pubmed-meshheading:16573786-Bilirubin, pubmed-meshheading:16573786-Biological Markers, pubmed-meshheading:16573786-Continental Population Groups, pubmed-meshheading:16573786-Esophageal and Gastric Varices, pubmed-meshheading:16573786-Female, pubmed-meshheading:16573786-Gastric Mucosa, pubmed-meshheading:16573786-Hepatitis C, Chronic, pubmed-meshheading:16573786-Humans, pubmed-meshheading:16573786-Hypertension, Portal, pubmed-meshheading:16573786-Insulin Resistance, pubmed-meshheading:16573786-Liver Cirrhosis, pubmed-meshheading:16573786-Liver Diseases, pubmed-meshheading:16573786-Male, pubmed-meshheading:16573786-Middle Aged, pubmed-meshheading:16573786-Platelet Count, pubmed-meshheading:16573786-Prevalence, pubmed-meshheading:16573786-Serum Albumin, pubmed-meshheading:16573786-Smoking, pubmed-meshheading:16573786-Stomach Diseases
pubmed:year
2006
pubmed:articleTitle
Portal hypertensive gastropathy in chronic hepatitis C patients with bridging fibrosis and compensated cirrhosis: results from the HALT-C trial.
pubmed:affiliation
Division of Gastroenterology, University of Michigan Medical Center, Ann Arbor, Michigan, USA.
pubmed:publicationType
Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't, Research Support, N.I.H., Extramural